Inogen, Inc. (INGN)

NASDAQ • Healthcare

$7.1

+$0.05 (+0.9%)

Market closed

Last close at October 23, 2026 at 20:00 UTC

Open$7.02

Day Range$6.98 - $7.16

Avg. Volume (3M)329.5K

Market Cap$188.4M

52 Week Range

$5.05$8.94

Next EarningsIn 11 daysNov 5, 2026

Metrics Over Time

Where the Money Goes

Q2 2026

Revenueeverything earned$95M100%

Gross Profitminus cost of goods$43.2M46%

In plain terms: out of every $100 in revenue, Inogen, Inc. currently loses $4.

Fundamentals & Financials

Revenue (TTM)

$354.3M

Net Income (TTM)

-$24.5M

EPS (TTM)

-$0.9

ROA (TTM)

-8.61%

Current Ratio

2.74

Dividend Yield

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement

Balance Sheet

Financial Highlights

Dividends History

Split History

Earnings

+31.8%Q3 2025-$0.15

+9.1%Q4 2025-$0.2

+27.8%Q1 2026-$0.26

-25.0%Q2 2026-$0.3

+8.7%Q3 2026-$0.14

Nov 5

in 11 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Next report — what to expect

Inogen, Inc. (INGN) reports earnings on November 4, 2026. Wall Street is looking for consensus EPS of -$0.11 on revenue of $92.2 million; for trailing context, revenue was up +3.0% year over year last quarter. INGN has beaten EPS in 7 of 8 most recent quarters, making profitability and sales execution key items to watch.

View full earnings history

About Inogen, Inc.

Inogen, Inc. is a NASDAQ-listed healthcare company focused on respiratory medical devices, designing, fabricating, and distributing oxygen concentration equipment that provides continuous oxygen support for people managing persistent respiratory conditions. In FY2025, it generated $348.7 million in revenue through portable and stationary oxygen systems, ventilators, and related accessories.

Name

Inogen, Inc.

CEO

Kevin R. Smith

Website

www.inogen.com

Industry

Healthcare

Year Founded

2001

Employees

753

Today's Snapshot

AI-generated

The day ended with INGN 0.8% higher at 7.10, outperforming a weaker sector. Earnings are due from INGN on 5 November.

Trading Volume

Below 10d avg (263.8K)

239.2K

vs S&P 500 Today

Outperforming Market

+1.37%

Updated: October 23, 2026 at 20:26 UTC

Technical Indicators

6 Buy0 Neutral2 Sell

INGN is showing a strong technical bias as a well-defined uptrend is supported by a high ADX reading and price sitting above short-, medium- and long-term moving averages, with the current level modestly above the pivot. Momentum indicators are robust — RSI is elevated and MACD is positive while CCI also shows bullish momentum — suggesting leadership in the move, and on-balance volume is aligned with buying pressure. Volatility is moderate by ATR, so moves are orderly rather than erratic. Technical takeaway: momentum-led, broad moving-average support underpins a strong-buy stance.

All signals

EMA (5 indicators)$5.99 - $6.59
Buy
RSI (14)75.81
Sell
Stochastic %K (14, 3, 3)92.37
Sell
MACD Level (12, 26)0.36
Buy

Peers & Related Assets

CATXPerspective Therapeutics, Inc.

$1.61-28.8%

QTRXQuanterix Corporation

$2.86+0.7%

HCATHealth Catalyst, Inc.

$1.69-2.9%

NNOXNano-X Imaging Ltd.

$0.37-2.9%

SGHTSight Sciences, Inc.

EPRXEupraxia Pharmaceuticals Inc.

Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.